Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.

Anne-Claire FougerousseM PerrusselP-A BécherelE BegonV PallureI ZaraaG ChabyJ ParierM KemulaL Mery-BossardC PoreauxCharles TaïebF MaccariZ Reguiainull null

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
sars cov
chronic kidney disease
rheumatoid arthritis
prognostic factors
early onset
patient reported outcomes
drug induced